Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05356910 · ClinicalTrials.gov registry record · NA

Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP

A NA study of HIV, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT05356910 is a NA study of HIV that has completed, run by University of California, San Diego. The registered enrollment target is 78 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05356910, a NA study of HIV, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

Onboarding Positives and PrEP users to Engage Negatives (OPPEN) is an intervention to train young men who have sex with men (YMSM) of color living with HIV or using pre-exposure prophylaxis (PrEP) to promote PrEP use among HIV-negative YMSM of color in their social networks. This pilot randomized controlled trial will evaluate OPPEN's acceptability, feasibility, and preliminary effect on PrEP care engagement among YMSM of color.

Conditions Studied

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL OPPEN

Study Locations (1)

California

  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2022-04-07
Est. Completion 2024-08-31
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05356910

The ClinicalTrials.gov registry entry for NCT05356910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Control Condition is the first listed.

NCT05356910 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05356910 about?

NCT05356910 is a clinical study titled "Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP". Onboarding Positives and PrEP users to Engage Negatives (OPPEN) is an intervention to train young men who have sex with men (YMSM) of color living with HIV or using pre-exposure prophylaxis (PrEP) to promote PrEP use among HIV-negative YMSM of color in their social networks. This pilot randomized co...

What is the current status of trial NCT05356910?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2022-04-07. Estimated completion is 2024-08-31.

What conditions does trial NCT05356910 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT05356910?

The interventions under investigation include: Control Condition (BEHAVIORAL), OPPEN (BEHAVIORAL).

Who is sponsoring clinical trial NCT05356910?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05356910 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.